APA (7th ed.) Citation

MT, W., N, R., RL, W., M, F., Y, F., D, D., . . . M, R. (2024). Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial. Annals of surgical oncology, 31(12), 7998. https://doi.org/10.1245/s10434-024-15980-9

Chicago Style (17th ed.) Citation

MT, Waheed, et al. "Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial." Annals of Surgical Oncology 31, no. 12 (2024): 7998. https://doi.org/10.1245/s10434-024-15980-9.

MLA (9th ed.) Citation

MT, Waheed, et al. "Impact of PIPAC-Oxaliplatin on Functional Recovery, Good Days, and Survival in a Refractory Colorectal and Appendiceal Carcinomatosis: Secondary Analysis of the US PIPAC Collaborative Phase 1 Trial." Annals of Surgical Oncology, vol. 31, no. 12, 2024, p. 7998, https://doi.org/10.1245/s10434-024-15980-9.